Point72 Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Point72 Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-269,600	Closed	-$4.61M	–	1383
2021 Q3	$4.61M	Buy	+269,600	New	+$4.2M	0.02%	674
2020 Q4	–	Sell	-679,281	Closed	-$37.2M	–	1209
2020 Q3	$37.2M	Buy	679,281 +555,696	+450%	+$29.9M	0.19%	141
2020 Q2	$7.11M	Buy	123,585 +70,449	+133%	+$3.83M	0.05%	410
2020 Q1	$2.13M	Buy	+53,136	New	+$2.26M	0.02%	496
2019 Q2	–	Sell	-400,000	Closed	-$5.56M	–	1614
2019 Q1	$5.56M	Buy	+400,000	New	+$4.57M	0.03%	538
2016 Q1	–	Sell	-19,400	Closed	-$157K	–	891
2015 Q4	$157K	Buy	+19,400	New	+$137K	﹤0.01%	653
2015 Q3	–	Sell	-400	Closed	-$3K	–	936
2015 Q2	$3K	Buy	+400	New	+$3.18K	﹤0.01%	700

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asset Management's CCXI Position: Q4 2021 in Review

Point72 Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2021, closing a stake of 269,600 shares — an estimated $4.61M sold.

Point72 Asset Management first reported a position in CCXI in Q2 2015 and held it in 7 quarters. The position peaked at $37.2M in Q3 2020. 190 funds tracked by Wall St. Rank hold CCXI as of Q4 2021.

Point72 Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2021 after selling out during the quarter.
Point72 Asset Management sold 269,600 ChemoCentryx, Inc. shares in Q4 2021, an estimated $4.61M.
Point72 Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2015 and held it in 7 quarters.
Point72 Asset Management's ChemoCentryx, Inc. position peaked at $37.2M in Q3 2020.
190 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2021.

Based on Point72 Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.